Comparison of Two Biphasic Insulin Aspart 30 Treatment Regimens in Subjects With Type 2 Diabetes Not Achieving HbA1c Treatment Targets on OADs Alone

NCT01215435 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

245

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: biphasic insulin aspart 30
DRUG: biphasic insulin aspart 30

Sponsor

Novo Nordisk A/S